Wealthspire Advisors (New York)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $297K | Buy |
2,681
+437
| +19% | +$48.4K | ﹤0.01% | 668 |
|
2025
Q1 | $251K | Sell |
2,244
-442
| -16% | -$49.5K | ﹤0.01% | 684 |
|
2024
Q4 | $248K | Buy |
+2,686
| New | +$248K | ﹤0.01% | 689 |
|
2023
Q1 | – | Sell |
-5,368
| Closed | -$461K | – | 555 |
|
2022
Q4 | $461K | Buy |
+5,368
| New | +$461K | 0.01% | 381 |
|
2022
Q1 | – | Sell |
-6,716
| Closed | -$488K | – | 483 |
|
2021
Q4 | $488K | Sell |
6,716
-261
| -4% | -$19K | 0.01% | 325 |
|
2021
Q3 | $487K | Buy |
+6,977
| New | +$487K | 0.01% | 360 |
|
2021
Q2 | – | Sell |
-9,177
| Closed | -$593K | – | 492 |
|
2021
Q1 | $593K | Buy |
9,177
+2,426
| +36% | +$157K | 0.01% | 353 |
|
2020
Q4 | $393K | Sell |
6,751
-566
| -8% | -$32.9K | 0.01% | 354 |
|
2020
Q3 | $462K | Sell |
7,317
-2,707
| -27% | -$171K | 0.03% | 190 |
|
2020
Q2 | $771K | Sell |
10,024
-7,947
| -44% | -$611K | 0.05% | 120 |
|
2020
Q1 | $1.34M | Buy |
17,971
+12,644
| +237% | +$946K | 0.06% | 161 |
|
2019
Q4 | $346K | Buy |
5,327
+99
| +2% | +$6.43K | 0.03% | 131 |
|
2019
Q3 | $331K | Buy |
+5,228
| New | +$331K | 0.03% | 108 |
|
2019
Q1 | – | Sell |
-850
| Closed | -$53K | – | 337 |
|
2018
Q4 | $53K | Buy |
+850
| New | +$53K | 0.01% | 178 |
|